Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeatedly-Administered THC-cannabis on Experimental Pain and Abuse Liability
NCT04596644Phase 2Suspended
- Sponsor
- New York State Psychiatric Institute
- Start
- Aug 2021
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabis in pain, sponsored by New York State Psychiatric Institute. Started Aug 2021; status: suspended.
02
Drugs
cannabis
03
Conditions
pain
Beyond the preview
Go deeper on NCT04596644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04596644.